---
title: "Deltex Medical Sees Increased Stake as It Expands Market Reach"
date: "2025-02-12 02:12:36"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioThe latest announcement is out from..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1306769920-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

The latest announcement is out from Deltex Medical ( [(GB:DEMG)](https://www.tipranks.com/stocks/gb:demg) ).

Deltex Medical announced a significant increase in its shareholding with John Reilly purchasing 10,000,000 ordinary shares, bringing his total to 6.12% of the company’s issued share capital. This development could enhance Deltex Medical’s market positioning as it continues to expand the application of its innovative TrueVue System, potentially improving its stake in the healthcare industry and offering substantial benefits to stakeholders by broadening its addressable market with new non-invasive technology.

**More about Deltex Medical**

Deltex Medical Group PLC specializes in haemodynamic monitoring technology, providing solutions to improve patient outcomes and increase hospital capacity. The company’s flagship product, the TrueVue System, incorporates both minimally invasive and non-invasive technologies, including the oesophageal Doppler monitoring (ODM) system. Deltex Medical targets a diverse market including anaesthetists, intensivists, and other healthcare settings like Accident & Emergency and general wards across global hospital systems.

**YTD Price Performance:** -60.0%

**Average Trading Volume:** 15,553,789

**Technical Sentiment Consensus Rating:** Strong Buy

**Current Market Cap:** £758.4K

See more insights into DEMG stock on [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/gb:demg/stock-analysis).

Trending Articles:
------------------

* [Coca-Cola (NYSE:KO) Plans Pivot to Plastic Against Aluminum Tariffs](https://www.tipranks.com/news/coca-cola-nyseko-plans-pivot-to-plastic-against-aluminum-tariffs)
* [TD Bank’s (TSE:TD) Schwab Sale Proves Better Than Expected](https://www.tipranks.com/news/td-banks-tsetd-schwab-sale-proves-better-than-expected)
* [Last-Minute Thought: J.P. Morgan Weighs In on Super Micro Computer Stock Ahead of Earnings](https://www.tipranks.com/news/last-minute-thought-j-p-morgan-weighs-in-on-super-micro-computer-stock-ahead-of-earnings)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/deltex-medical-sees-increased-stake-as-it-expands-market-reach)
